These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 21621084)

  • 21. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM; Khera M; Bhattacharya RK; Blick G; Kushner H
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement therapy in males with erectile dysfunction.
    Jacob BC
    J Pharm Pract; 2011 Jun; 24(3):298-306. PubMed ID: 21676853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is hypoandrogenemia a component of metabolic syndrome in males?
    Singh SK; Goyal R; Pratyush DD
    Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):30-5. PubMed ID: 20690073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Patient with testosterone deficit syndrome and dyslipemia].
    Sola Galarza I; López López B; Llorente Abarca C
    Arch Esp Urol; 2013 Sep; 66(7):752-9. PubMed ID: 24047636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sexual dysfunction in male: a matter of old age or a warning signal?].
    Stadler TC; Stief CG; Becker AJ
    MMW Fortschr Med; 2009 Apr; 151(14):72-4, 76; quiz 78. PubMed ID: 19504845
    [No Abstract]   [Full Text] [Related]  

  • 27. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism.
    Maggi M; Filippi S; Vignozzi L; Rastrelli G
    Andrology; 2020 Nov; 8(6):1580-1589. PubMed ID: 32248652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does testosterone have a role in erectile function?
    Mikhail N
    Am J Med; 2006 May; 119(5):373-82. PubMed ID: 16651047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The testosterone storm.
    Gomella LG
    Can J Urol; 2015 Apr; 22(2):7677. PubMed ID: 25891328
    [No Abstract]   [Full Text] [Related]  

  • 30. Androgen deficiency in the etiology and treatment of erectile dysfunction.
    Gore JL; Swerdloff RS; Rajfer J
    Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome.
    Filippi S; Vignozzi L; Morelli A; Chavalmane AK; Sarchielli E; Fibbi B; Saad F; Sandner P; Ruggiano P; Vannelli GB; Mannucci E; Maggi M
    J Sex Med; 2009 Dec; 6(12):3274-88. PubMed ID: 19732305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Testosterone deficiency, metabolic syndrome and diabetes mellitus].
    Fernández-Miró M; Chillarón JJ; Pedro-Botet J
    Med Clin (Barc); 2016 Jan; 146(2):69-73. PubMed ID: 26433309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone, cardiovascular disease and the metabolic syndrome.
    Corona G; Rastrelli G; Vignozzi L; Mannucci E; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):337-53. PubMed ID: 21397202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting.
    Knoblovits P; Costanzo PR; Valzacchi GJ; Gueglio G; Layus AO; Kozak AE; Balzaretti MI; Litwak LE
    J Androl; 2010; 31(3):263-70. PubMed ID: 19834133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to lessen cardiovascular risk and all-cause mortality?
    Miner MM; Seftel AD
    Int J Clin Pract; 2010 Dec; 64(13):1754-62. PubMed ID: 21070526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency.
    Yassin AA; Akhras F; El-Sakka AI; Saad F
    Andrologia; 2011 Feb; 43(1):1-8. PubMed ID: 21219375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.